The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Open accessAbstract
Cancer incidence is rising and this global challenge is further exacerbated by tumour resistance to available medicines. A promising approach to meet the need for improved cancer treatment is drug repurposing. Here we highlight the potential for repurposing disulfiram (also known by the trade name Antabuse), an old alcohol-aversion drug that has been shown to be effective against diverse cancer types in preclinical studies. Our nationwide epidemiological study reveals that patients who continuously used disulfiram have a lower risk of death from cancer compared to those who stopped using the drug at their diagnosis. Moreover, we identify the ditiocarb-copper complex as the metabolite of disulfiram that is responsible for its anti-cancer effects, and provide methods to detect preferential accumulation of the complex in tumours and candidate biomarkers to analyse its effect on cells and tissues. Finally, our functional and biophysical analyses reveal the molecular target of disulfiram's tumour-suppressing effects as NPL4, an adaptor of p97 (also known as VCP) segregase, which is essential for the turnover of proteins involved in multiple regulatory and stress-response pathways in cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DIS`s definitive antineoplastic mechanism of action, identified over the past decade, involves the molecular target NPL4, which is an adapter for the p97/VCP segregase and is essential for protein turnover, playing a role in several regulatory and stress-responsive cellular pathways.26”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a nationwide epidemiological study revealed that patients who continuously used DIS have a lower risk of death from cancer compared to those who stopped using the drug at their diagnosis.26”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“This triggers a multifaceted cellular stress response culminating in cell death,26”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“Intracellular Cu(DDC)2 binds NPL4, inducing aggregation that disrupts the essential p97-NPL4-UFD1 segregase pathway.”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“DIS’s cytotoxic activity stems from its rapid metabolism to Cu(DDC)2, which preferentially accumulates in tumors.”
From Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence (2026) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“This initial observation has since been substantiated through extensive research, including analyses of Danish demographic and health registries that observed lower mortality rates for colon, prostate, and breast cancers among ongoing DSF users compared to former users.111”
From Drug repurposing for cancer therapy (2024) · cites this paper as [111]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Molecular Chaperone Functions in Protein Folding and Proteostasis
Kim, Y., Hipp, M. S., Bracher, A., Hayer-Hartl, M. K., & Hartl, F. U. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060208-092442 · Cited by 1,545
Target identification using drug affinity responsive target stability (DARTS)
Lomenick, B., Hao, R., Jonai, N., Chin, R., Aghajan, M., Warburton, S., Wang, J., Wu, R. P., Gómez, F., Loo, J. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910040106 · Cited by 1,130
Thygesen, L. C., Daasnes, C., Thaulow, I., & Brønnum‐Hansen, H. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811399956 · Cited by 1,089
Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26 S Proteasome
Verma, R., Aravind, L., Oania, R. S., McDonald, W. H., Yates, J. R., Koonin, E. V., & Deshaies, R. J. (2002) · Science · doi:10.1126/science.1075898 · Cited by 994
Self-citationDoil, C., Mailand, N., Bekker‐Jensen, S., Ménard, P., Larsen, D. H., Pepperkok, R., Ellenberg, J., Panier, S., Durocher, D., Bártek, J., et al. (2009) · Cell · doi:10.1016/j.cell.2008.12.041 · Cited by 982
Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system
Meyer, H. H., Bug, M., & Bremer, S. (2012) · Nature Cell Biology · doi:10.1038/ncb2407 · Cited by 832
Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 683
Self-citationCell death assays for drug discovery
Kepp, O., Galluzzi, L., Lipinski, M. M., Yuan, J., & Kroemer, G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3373 · Cited by 587
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Becker, L. A., Huang, B., Bieri, G., Ma, R., Knowles, D. A., Jafar-Nejad, P., Messing, J., Kim, H. J., Soriano, A., Auburger, G., et al. (2017) · Nature · doi:10.1038/nature22038 · Cited by 571
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 812
Werlenius, K., Kinhult, S., Solheim, T. S., Magelssen, H., Löfgren, D., Mudaisi, M., Hylin, S., Bartek, J. J., Strandéus, M., Lindskog, M., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.4149 · Cited by 78
Self-citationBakthavatsalam, S., Sleeper, M. L., Dharani, A. M., George, D. J., Zhang, T., & Franz, K. J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807582 · Cited by 74
Sun, T., Yang, W., Toprani, S. M., Guo, W., He, L., DeLeo, A. B., Ferrone, S., Zhang, G., Wang, E., Lin, Z., et al. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-019-0507-3 · Cited by 74
Huang, Y., Fang, J., Lü, W., Wang, Z., Wang, Q., Hou, Y., Jiang, X., Reizes, O., Lathia, J. D., Nussinov, R., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.05.004 · Cited by 73
Copper and Copper Complexes in Tumor Therapy
Wang, Y., Tang, T., Yuan, Y., Li, N., Wang, X., & Guan, J. (2024) · ChemMedChem · doi:10.1002/cmdc.202400060 · Cited by 74
Cuproptosis in cancer: biological implications and therapeutic opportunities
Li, L., Zhou, H., & Zhang, C. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00608-3 · Cited by 75
Huang, X. Y., Hou, Y., Weng, X., Pang, W., Hou, L., Liang, Y., Wang, Y., Du, L., Wu, T., Yao, M., et al. (2021) · Oncogenesis · doi:10.1038/s41389-020-00295-7 · Cited by 71
Hogarth, G., & Onwudiwe, D. C. (2021) · Inorganics · doi:10.3390/inorganics9090070 · Cited by 72
Chemical Synthesis of Human Proteoforms and Application in Biomedicine
Ai, H., Pan, M., & Liu, L. (2024) · ACS Central Science · doi:10.1021/acscentsci.4c00642 · Cited by 71
Huddle, B. C., Grimley, E. C., Buchman, C. D., Chtcherbinine, M., Debnath, B., Mehta, P., Yang, K., Morgan, C. A., Li, S., Felton, J. A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00930 · Cited by 71
Wang, J., Wang, X., He, Y., Jia, L., Yang, C. S., Reiter, R. J., & Zhang, J. (2019) · Cells · doi:10.3390/cells8080903 · Cited by 70
Pan, Q., Peng, X., Cun, J., Li, J., Pu, Y., & He, B. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.128222 · Cited by 69
Self-citationCu-related agents for cancer therapies
Wang, C., Yang, X., Dong, C., Chai, K., Ruan, J., & Shi, S. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215156 · Cited by 68
Selective Secretase Targeting for Alzheimer’s Disease Therapy
Miranda, A., Montiel, E., Ulrich, H., & Paz, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201027 · Cited by 66
“Its lipophilic profile enables the compound of crossing the blood-brain barrier [55].”
Chen, J., Han, X., Deng, J., Zhang, J., Li, L., Ni, J., Huang, Y., Xie, X., Chen, S., Ke, L., et al. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.127423 · Cited by 66
Wan, W., Jin, W., Huang, Y., Xia, Q., Bai, Y., Lyu, H., Liu, D., Dong, X., Li, W., & Liu, Y. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04309 · Cited by 66
Kita, Y., Hamada, A., Saito, R., Teramoto, Y., Tanaka, R., Takano, K., Nakayama, K., Murakami, K., Matsumoto, K., Akamatsu, S., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0609-0 · Cited by 64
N-terminal Domain of TDP43 Enhances Liquid-Liquid Phase Separation of Globular Proteins
Carter, G. C., Hsiung, C., Simpson, L., Yang, H., & Zhang, X. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.166948 · Cited by 65
Disulfiram: A novel repurposed drug for cancer therapy
Min De, Z. E. N. G., Wu, B., Wei, W., Jiang, Z., Li, P., Quan, Y., & Hu, X. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002909 · Cited by 66
A Modular Ionophore Platform for Liver-Directed Copper Supplementation in Cells and Animals
Su, T. A., Shihadih, D. S., Cao, W., Detomasi, T. C., Heffern, M. C., Jia, S., Stahl, A., & Chang, C. J. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08014 · Cited by 67
Aldehyde dehydrogenase-2 as a therapeutic target
Kimura, M., Yokoyama, A., & Higuchi, S. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1690454 · Cited by 64
The Disulfiram/Copper Complex Induces Autophagic Cell Death in Colorectal Cancer by Targeting ULK1
Hu, Y., Qian, Y., Wei, J., Jin, T., Kong, X., Cao, H., & Ding, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.752825 · Cited by 63
Pan, Q., Xie, L. W., Liu, R., Pu, Y., Wu, D., Gao, W., Luo, K., & He, B. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121351 · Cited by 63
Spillier, Q., Vertommen, D., Ravez, S., Marteau, R., Thémans, Q., Corbet, C., Feron, O., Wouters, J., & Frédérick, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-41187-0 · Cited by 62
Wang, Z., Chen, C., Wang, Y., Li, F., Huang, J., Luo, Z., Rao, S., Tan, Y., Liu, Y., Yin, H., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201808556 · Cited by 62
Xu, R., Zhang, K., Liang, J., Gao, F., Li, J., & Guan, F. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.117846 · Cited by 62
Self-citationGlutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy
Chen, M., Huang, Z., Xia, M., Ding, Y., Shan, T., Guan, Z., Dai, X., Xu, X., Huang, Y., Huang, M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.041 · Cited by 62
Li, J., Zhang, Z., Li, J., Cun, J., Pan, Q., Gao, W., Luo, K., He, B., Gu, Z., & Pu, Y. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.08.076 · Cited by 62
Self-citationQi, J., Yao, Q., Tian, L., & Wang, Y. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.034 · Cited by 62
Chang, Y., Jiang, J., Wu, C., Yang, W. L., Chen, L., Chen, P., Shen, J., Qian, S., Zhou, T., Wu, L., et al. (2019) · Applied Materials Today · doi:10.1016/j.apmt.2019.100492 · Cited by 63
Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment
Yang, H., Chen, X., Li, K., Cheaito, H. A., Yang, Q., Wu, G., Liu, J., & Dou, Q. P. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.013 · Cited by 62
Self-citationLi, P., Sun, Q., Bai, S., Wang, H., & Zhao, L. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5343 · Cited by 63
Wang, J., Li, J., Liu, J., Chan, K.-Y., Lee, J. H. S., Lin, K. N., Wang, C. C., & Lau, T. (2024) · Cancers · doi:10.3390/cancers16030512 · Cited by 64
Self-citationXu, M., Casio, M., Range, D. E., Sosa, J. A., & Counter, C. M. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3705 · Cited by 61
AAA+ ATPases in Protein Degradation: Structures, Functions and Mechanisms
Zhang, S., & Mao, Y. (2020) · Biomolecules · doi:10.3390/biom10040629 · Cited by 64
Chemoproteomic-enabled phenotypic screening
Conway, L. P., Li, W., & Parker, C. G. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.01.012 · Cited by 62
Li, Y., Li, Y., Yu, Y., Ren, X., Yang, C., Jin, W., Li, K., Zhou, Y., Wu, C., Shen, Y., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.06.006 · Cited by 60
Developing New Cancer Nanomedicines by Repurposing Old Drugs
Yang, B., & Shi, J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004317 · Cited by 61
Tang, H., Liu, C., Zhang, J.-T., Zheng, X., Yang, D., Kankala, R. K., Wang, S., & Chen, A. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c14636 · Cited by 59
Li, Y., Wang, Y., Li, Z., Stenzel, M. H., & Jiang, Y. (2024) · Materials Horizons · doi:10.1039/d4mh00470a · Cited by 60
Chen, J., Tan, X., Huang, Y., Xu, C., Zeng, Z., Shan, T., Guan, Z., Xu, X., Huang, Z., & Zhao, C. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121513 · Cited by 58
Disulfiram with Cu2+ alleviates dextran sulfate sodium-induced ulcerative colitis in mice
Zhou, W., Zhang, H., Huang, L., Sun, C., Yue, Y., Cao, X., Jia, H.-L., Wang, C., & Gao, Y. (2023) · Theranostics · doi:10.7150/thno.81571 · Cited by 58
The Cross-Communication of Cuproptosis and Regulated Cell Death in Human Pathophysiology
Tsui, K., Hsiao, J., Lin, L., Tsang, Y.-L., Shao, A., Kuo, C.-H., Chang, R., Wen, Z., & Li, C. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.84733 · Cited by 60
Computational repositioning of dimethyl fumarate for treating alcoholic liver disease
Zhang, Y., Zhao, S., Fu, Y., Lu, Y., Feng, Y., Chen, Y., Wu, Y., Deng, Y., Zhang, G., Chen, Y., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02890-3 · Cited by 58
Li, X., Xu, F., He, Y., Yan, L., Hou, J., Yang, G., & Zhou, S. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004851 · Cited by 58
Silver Complexes as Anticancer Agents: A Perspective Review
Raju, S. K., Kumar, S., Sekar, P., Murugesan, M., & Mohanapriya, K. (2022) · German Journal of Pharmaceuticals and Biomaterials · doi:10.5530/gjpb.2022.1.3 · Cited by 57
Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems
Kang, X., Jadhav, S., Annaji, M., Huang, C.-H., Amin, R., Shen, J., Ashby, C. R., Tiwari, A. K., Babu, R. J., & Chen, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061567 · Cited by 60
Santoro, A., Calvo, J. S., Peris‐Díaz, M. D., Krężel, A., Meloni, G., & Faller, P. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201916316 · Cited by 57
Liu, Y., Guan, X., Wang, M., Wang, N., Chen, Y., Li, B., Xu, Z., Fu, F., Du, C., & Zheng, Z. (2022) · Bioengineered · doi:10.1080/21655979.2022.2038434 · Cited by 56
Skaga, E., Skaga, I. Ø., Grieg, Z., Sandberg, C. J., Langmoen, I. A., & Vik-Mo, E. O. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-02920-4 · Cited by 55
Xu, Y., Zhou, Q., Feng, X., Dai, Y., Jiang, Y. Z., Jiang, W., Liu, X., Xing, X., Wang, Y., Ni, Y., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110048 · Cited by 55
Tumor-responsive copper-activated disulfiram for synergetic nanocatalytic tumor therapy
Chen, H., Li, X., Huo, M., Wang, L., Chen, Y., Chen, W., & Wang, B. (2020) · Nano Research · doi:10.1007/s12274-020-3069-1 · Cited by 55
Copper in colorectal cancer: From copper‐related mechanisms to clinical cancer therapies
Wang, Y., Pei, P., Yang, K., Guo, L., & Li, Y. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1724 · Cited by 56
Tan, W. W., Wang, C., & Jiang, X. (2018) · Organic Chemistry Frontiers · doi:10.1039/c8qo00481a · Cited by 53
Mitochondrial dysfunction, UPRmt signaling, and targeted therapy in metastasis tumor
Keerthiga, R., Pei, D., & Fu, A. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00696-0 · Cited by 53
Conductive Polymer Coated Scaffold to Integrate 3D Cell Culture with Electrochemical Sensing
Zhang, H., Hu, X., Qin, Y., Jin, Z., Zhang, X., Liu, Y., & Huang, W. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00478 · Cited by 53
Zhao, P., Zhang, J., Wu, A., Zhang, M., Zhao, Y., Tang, Y., Wang, B., Chen, T., Li, F., Zhao, Q., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.052 · Cited by 52
The role of pyroptosis in modulating the tumor immune microenvironment
Wu, J., Wang, L., & Xu, J. (2022) · Biomarker Research · doi:10.1186/s40364-022-00391-3 · Cited by 51
Targeting glycolysis for cancer therapy using drug delivery systems
Huang, Y. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.003 · Cited by 51
Wang, Y., Drum, D. L., Sun, R., Zhang, Y., Chen, F., Sun, F., Dal, E., Yu, L., Jia, J., Arya, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41282-x · Cited by 51
Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate
You, S.-Y., Rui, W., Chen, S.-T., Chen, H.-C., Liu, X., Huang, J., & Chen, H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.192 · Cited by 51
Xu, Y., Kong, Y., Xu, J., Li, X., Gou, J., Yin, T., He, H., Zhang, Y. X., & Tang, X. (2019) · Biomaterials Science · doi:10.1039/c9bm01394f · Cited by 51
Peng, Y., Liu, P., Meng, Y., Hu, S., Ding, J., & Zhou, W. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00284 · Cited by 51
Targeting Ubiquitin–Proteasome System With Copper Complexes for Cancer Therapy
Chen, X., Dou, Q. P., Liu, J., & Tang, D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.649151 · Cited by 51
Self-citationDisulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma—Old Myth or New Logos?
Meraz-Torres, F., Plöger, S., Garbe, C., Niessner, H., & Sinnberg, T. W. (2020) · Cancers · doi:10.3390/cancers12123538 · Cited by 51
Cuproplasia and cuproptosis, two sides of the coin
Lu, K., Wijaya, C. S., Yao, Q., Jin, H., & Feng, L. (2025) · 癌症：英文版 · doi:10.1002/cac2.70001 · Cited by 51
Dodda, J. M., Remiš, T., Sadiku, E. R., & Yeh, Y. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00469k · Cited by 49
Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death
Park, Y. M., Go, Y. Y., Shin, S. H., Cho, J., Woo, J., & Song, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203069 · Cited by 49
Parzych, K., Saavedra-García, P., Valbuena, G. N., Al-Sadah, H. A., Robinson, M. E., Penfold, L., Kuzeva, D. M., Ruiz-Tellez, A., Loaiza, S., Holzmann, V., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0651-z · Cited by 51
Small molecule grp94 inhibitors block dengue and Zika virus replication
Rothan, H. A., Zhong, Y., Sanborn, M. A., Teoh, T. C., Ruan, J., Yusof, R., Hang, J., Henderson, M. J., & Fang, S. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.104590 · Cited by 50
Disulfiram as a potent metallo-β-lactamase inhibitor with dual functional mechanisms
Chen, C., Yang, K., Wu, L., Li, J., & Sun, L.-Y. (2020) · Chemical Communications · doi:10.1039/c9cc09074f · Cited by 49
Self-citationDiscovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent
Lü, X., Liu, Y., Orvig, C., Liang, H., & Chen, Z. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02047 · Cited by 49
Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities
Shan, D., Jinling, S., Ren, Y., Zhang, Y., Ba, Y., Luo, P., Cheng, Q., Xu, H., Weng, S., Zuo, A., et al. (2025) · 癌症：英文版 · doi:10.1002/cac2.70005 · Cited by 53
Butcher, K., Kannappan, V., Kilari, R. S., Morris, M. R., McConville, C., Armesilla, A. L., & Wang, W. (2018) · BMC Cancer · doi:10.1186/s12885-018-4617-x · Cited by 48
Anticancer copper complex with nucleus, mitochondrion and cyclooxygenase-2 as multiple targets
Shi, X., Fang, H., Guo, Y., Yuan, H., Guo, Z., & Wang, X. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.10.003 · Cited by 48
Espinoza, J. A., Zisi, A., Kanellis, D. C., Puigvert, J. C., Henriksson, M., Hühn, D., Watanabe, K., Helleday, T., Lindström, M. S., & Bártek, J. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0387-5 · Cited by 49
Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
Shirley, D.-A. T., Sharma, I., Warren, C. A., & Moonah, S. N. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.633194 · Cited by 48
Emerging Roles of the Copper–CTR1 Axis in Tumorigenesis
Su, Y., Zhang, X., Li, S., Xie, W., & Guo, J. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0056 · Cited by 48
The endoplasmic reticulum stress response in prostate cancer
de la Calle, C. M., Shee, K., Yang, H., Lonergan, P. E., & Nguyen, H. G. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00649-3 · Cited by 47
Copper in hepatocellular carcinoma： A double-edged sword with therapeutic potentials
Wu, Z., Lv, G., Xing, F., Xiang, W., Ma, Y., Feng, Q., Yang, W. K., & Wang, H. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216348 · Cited by 48
Copper as the Target for Anticancer Nanomedicine
Shao, S., Si, J., & Shen, Y. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201800147 · Cited by 48
Nie, D., Chen, C., Li, Y., & Zeng, C. (2022) · Blood Science · doi:10.1097/bs9.0000000000000117 · Cited by 48
Role of cuproptosis in understanding diseases
Cao, S., Wang, Q., Sun, Z., Zhang, Y., Liu, Q., Huang, Q., Ding, G., & Jia, Z. (2023) · Human Cell · doi:10.1007/s13577-023-00914-6 · Cited by 46
Nanomedicine strategies for cuproptosis: Metabolic reprogramming and tumor immunotherapy
Zhang, R., Li, Y., Fu, H., Zhao, C., Li, X., Wang, Y., Sun, Y., & Li, Y. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.007 · Cited by 46
Tao, X., Gou, J., Zhang, Q., Tan, X., Ren, T., Yao, Q., Tian, B., Kou, L., Zhang, L., & Tang, X. (2018) · Biomaterials Science · doi:10.1039/c8bm00271a · Cited by 46
Soft and Condensed Nanoparticles and Nanoformulations for Cancer Drug Delivery and Repurpose
Yang, W. L., Veroniaina, H., Qi, X., Chen, P., Li, F., & Ke, P. C. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900102 · Cited by 46
Metformin and ovarian cancer: the evidence
Urpilainen, E., Puistola, U., Boussios, S., & Karihtala, P. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-1060 · Cited by 46
Hou, L., Liu, Y., Liu, W., Balash, M., Zhang, H., Zhang, Y., Zhang, H., & Zhang, Z. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.01.013 · Cited by 46
Metal complex-based liposomes: Applications and prospects in cancer diagnostics and therapeutics
Wang, Z., Li, J., Lin, G., He, Z., & Wang, Y. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.012 · Cited by 49
Self-citationGui, C., Wei, J., Chen, Y., Fu, L., Tang, Y., Cao, J., Chen, W., & Luo, J. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab173 · Cited by 46
Cheng, Z., Gu, L., Zhao, Y., Yang, L., Chen, L., Wang, T., Luo, M., Wei, J., & Li, P. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.127555 · Cited by 45
Zhuo, X., Tian, L., Miao, L., Chu, W., Li, X., Luo, L., Gou, J., Zhang, Y. X., Yin, T., He, H., et al. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.05.057 · Cited by 45
Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
Schmidtova, S., Kaľavská, K., Gercakova, K., Čierna, Z., Miklikova, S., Smolková, B., Buociková, V., Miskovska, V., Durinikova, E., Buríková, M., et al. (2019) · Cancers · doi:10.3390/cancers11091224 · Cited by 45
Wang, Q., Zhu, T., Miao, N., Qu, Y., Wang, Z., Chao, Y., Wang, J., Wu, W., Xu, X., Xu, C., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2022110636 · Cited by 45
Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies
Bian, C., Zheng, Z., Su, J., Chang, S., Yu, H., Bao, J., Xin, Y., & Jiang, X. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1271613 · Cited by 44
Zhang, M., Tian, J., Wang, R., Song, M., Zhao, R., Chen, H., Liu, K., Shim, J., Zhu, F., Dong, Z., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.556532 · Cited by 44
From symmetrical tetrasulfides to trisulfide dioxides via photocatalysis
Gong, K., Zhou, Y., & Jiang, X. (2021) · Green Chemistry · doi:10.1039/d1gc03242a · Cited by 44
Majera, D., Skrott, Z., Chroma, K., Merchut-Maya, J. M., Mistrik, M., & Bartek, J. (2020) · Cells · doi:10.3390/cells9020469 · Cited by 43
Self-citationShen, Y., Thng, D. K. H., Wong, A. L. A., & Toh, T. B. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00512-8 · Cited by 47
Metadata
- Authors
- Skrott, Z., Mistrik, M., Andersen, K. K., Friis, S., Majera, D., Gursky, J., Ozdian, T., Bartkova, J., Turi, Z., Moudry, P., Kraus, M., Michalova, M., Vaclavkova, J., Dzubak, P., Vrobel, I., Pouckova, P., Sedlacek, J., Miklovicova, A., Kutt, A., Li, J., Mattova, J., Driessen, C., Dou, Q. P., Olsen, J., Hajduch, M., Cvek, B., Deshaies, R. J., & Bartek, J.
- Affiliations
- Danish Cancer Society (DK)
- Institute of Molecular and Translational Medicine (CZ)
- Kantonsspital St. Gallen (CH)
- Charles University (CZ)
- Nemocnice Šternberk (CZ)
- California Institute of Technology (US)
- Wayne State University (US)
- Palacký University Olomouc (CZ)
- Corresponding author
- Cvek, Boris
- Deshaies, Raymond J.
- ORCID
- Venue
- Nature
- Published
- 2017-12
- Volume
- 552
- Issue
- 7684
- Pages
- 194-199
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5730499
- OpenAlex
- W2772508026
- Cited by
- 807
- References
- 53
- Citations by year
- 2026: 76 · 2025: 108 · 2024: 120 · 2023: 108 · 2022: 112 · 2021: 81 · 2020: 92 · 2019: 60 · 2018: 50
- FWCI
- 22.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Lundbeckfonden (R93-2011-8990)
- National Cancer Institute (R01CA164803)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- disulfiram, drug repurposing, cancer, Npl4, VCP, diethyldithiocarbamate, cancer mortality, tumor suppression, protein turnover, stress response, biomarkers, cell death
- MeSH terms
- Adult, Alcohol Deterrents, Alcoholism, Animals, Antineoplastic Agents, Copper, Denmark, Disulfiram, Female, Humans, Male, Middle Aged, Neoplasms, Nuclear Proteins, Protein Binding, Heat-Shock Response, Mice, Drug Repositioning, Molecular Targeted Therapy, Proteolysis, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
